Magnetic nanoformulation of azidothymidine 5’-triphosphate for targeted delivery across the blood–brain barrier

References

• PangSKoyangiYMilesSWileyCHarryVChenIHigh levels of unintegrated HIV-1 DNA in brain tissue of AIDS dementia patientsNature19903485892296295
   PubMed Web of Science ®Google Scholar
• SpencerDCPriceRWHuman immunodeficiency virus and the central nervous systemAnnu Rev Microbiol1992466556931444270
   PubMed Web of Science ®Google Scholar
• LiptonSAGendelmanHEDementia associated with the acquired immunodeficiency syndromeN Engl J Med19953329349407877652
   PubMed Web of Science ®Google Scholar
• LesniakMSBremHTargeted therapy for brain tumorsNat Rev Drug Discov20043649950815173839
   PubMed Web of Science ®Google Scholar
• NowacekAGendelmanHENanoART, neuroAIDS and CNS drug deliveryNanomed20094557574
   PubMed Web of Science ®Google Scholar
• SuriSSFenniriHSinghBNanotechnology-based drug delivery systemsJ Occup Med Toxicol200721618053152
   PubMedGoogle Scholar
• SarinHRecent progress towards the development of effective systemic chemotherapy for the treatment of malignant brain tumorsJ Transl Med200977719723323
   PubMed Web of Science ®Google Scholar
• HofmannHPetriAChastellainMHofmannMSuperparamagnetic nano-particle preparation for medical applicationEur Cell Mater200122930
   Google Scholar
• ItoAShinkaiMHondaHKobayashiTMedical application of functionalized magnetic nanoparticlesJ Biosci Bioeng200510011116233845
   PubMed Web of Science ®Google Scholar
• SafarikISafarikovaMMagnetic nanoparticles and biosciencesMon Chem2002133737759
   Web of Science ®Google Scholar
• ChertokBMoffatBADavidAEIron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumorsBiomaterials200829448749617964647
   PubMed Web of Science ®Google Scholar
• RiviereCMartinaMSRiviereCMagneting targeting of nanometric magnetic fluid loaded liposomes to specific brain intravascular areas: A dynamic imaging study in miceRadiology200724443944817562813
   PubMed Web of Science ®Google Scholar
• DouHGrotepasCBMcMillanJMMacrophage delivery of nanoformulated antiretroviral drug to the brain in a murine model of NeuroAIDSJ Immunol200918366166919535632
   PubMed Web of Science ®Google Scholar
• DouHDestacheCJMoreheadJRDevelopment of a macrophage-based nanoparticle platform for antiretroviral drug deliveryBlood20061082827283516809617
   PubMed Web of Science ®Google Scholar
• PerryVHAnthonyDCBoltonSJBrownHCThe blood-brain barrier and inflammatory responseMol Med19973335341
   Web of Science ®Google Scholar
• JainSMishraVSinghPDubeyPKSarafDKVyasSPRGD-anchored magnetic liposomes for monocytes/neutrophils-mediated brain targetingInt J Pharm2003261435512878394
   PubMed Web of Science ®Google Scholar
• SaiyedZMGandhiNHNairMPNAZT 5’-triphosphate nanoformulation suppresses HIV-1 replication in peripheral blood mononuclear cellsJ Neurovirol200915343347
   PubMed Web of Science ®Google Scholar
• PhillipsNCTsoukasCLiposomal encapsulation of azidothymidine results in decreased hematopoietic toxicity and enhanced activity against murine acquired immunodeficiency syndromeBlood1992795113711431371411
   PubMed Web of Science ®Google Scholar
• Steward-MarshallJCColorimetric determination of phospholipids with ammonium ferrothyocianateAnal Biochem198010410146892980
   PubMed Web of Science ®Google Scholar
• PersidskyYStinsMWayDA model for monocytes migration through the blood brain barrier during HIV-1 encephalitisJ Immunol1997158349935109120312
   PubMed Web of Science ®Google Scholar
• Martínez-EstradaOMRodríguez-MillánEGonzález-De VicenteEReinaMVilaróSFabreMErythropoietin protects the in vitro blood-brain barrier against VEGF-induced permeabilityEur J Neurosci20031892538254414622154
   PubMed Web of Science ®Google Scholar
• MolemaGJansenRWVisserJMeijerDKSimultaneous analysis of azidothymidine and its mono-, di-and triphosphate derivatives in biological fluids, tissue and cultured cells by a rapid high-performance liquid chromatographic methodJ Chromatogr1992579104114
   Web of Science ®Google Scholar
• GandhiNHSaiyedZMThangavelSRodriguezJRaoKVKNairMPNDifferential effect of HIV-1 clade B and clade C Tat protein on expression of pro- and anti-inflammatory cytokines by primary monocytesAIDS Res Human Retrovir20092569169919621989
   PubMed Web of Science ®Google Scholar
• SaiyedZMTelangSDRamchandCNApplication of magnetic techniques in the field of drug discovery and biomedicineBioMagn Res Technol200311812646069
   PubMedGoogle Scholar
• PankhurstQAConnollyJJonesSKDobsonJApplications of magnetic nanoparticles in biomedicineJ Phys D Appl Phys20033613167181
   Web of Science ®Google Scholar
• HaorahJKnipeBLeibhartJGhorpadeAPersidskyYAlcohol-induced oxidative stress in brain endothelial cells causes blood-brain barrier dysfunctionJ Leukoc Biol2005781223123216204625
   PubMed Web of Science ®Google Scholar
• AferganEEpsteinHDahanRDelivery of serotonin to the brain by monocytes following phagocytosis of liposomesJ Control Release2008132849018805446
   PubMed Web of Science ®Google Scholar
• BatrakovaEVLiSReynoldsADA macrophage-nanozyme delivery system for parkinson’s diseaseBioconjugate Chem20071814981506
   PubMed Web of Science ®Google Scholar
• MuthanaMScottSDFarrowNA novel magnetic approach to enhance the efficacy of cell-based gene therapiesGene Therapy20081590291018418420
   PubMed Web of Science ®Google Scholar
• RobertsonKRHallCDAssessment of NeuroAIDS in the International settingJ Neuroimmune Pharmacol2007210511118040833
   PubMed Web of Science ®Google Scholar
• MurriRLepriACPaolaCIs moderate HIV viremia associated with a higher risk of clinical progression in HIV-infected people treated with highly active antiretroviral therapy: evidence from the Italian Cohort of Antiretroviral-Naïve Patients StudyJ Acquir Immune Defic Syndr200641233016340469
   PubMed Web of Science ®Google Scholar
• KohliEHanHYZemanADVinogradovSVFormulations of biodegradable nanogel carriers with 5’-triphosphates of nucleoside analogs that display a reduced cytotoxicity and enhanced drug activityJ Control Release2007121192717509713
   PubMed Web of Science ®Google Scholar
• Doualla-BellFTurnerDLoembaHPetrellaMBrennerBWainbergMAHIV drug resistance and optimization of antiviral treatment in resource-poor countriesMed Sci200420882886
   Google Scholar
• AntonelliGTurrizianiOVerriALong-term exposure to zidovudine affects in vitro and in vivo the efficiency of phosphorylation of thymidine kinaseAIDS Res Hum Retrovir1996122232288835200
   PubMed Web of Science ®Google Scholar
• SilvaGANanotechnology approaches for drug and small molecule delivery across the blood brain barrierSurg Neurol20076711311617254859
   PubMed Web of Science ®Google Scholar
• SzebeniJWahlSMBetageriGVInhibition of HIV-1 in monocyte/macrophage cultures by 2’,3’-dideoxycytidine-5’-triphosphate, free and in liposomesAIDS Res Hum Retroviruses199066917022163269
   PubMed Web of Science ®Google Scholar
• VinogradovSVKohliEZemanADCrosslinked polymeric nanogel formulation of 5’-triphosphates of nucleoside analogs: role of the cellular membrane in drug releaseMol Pharm2005244946116323952
   PubMed Web of Science ®Google Scholar
• MagnaniMRossiLFraternaleAFeline immunodeficiency virus infection of macrophages: in vitro and in vivo inhibition by dideoxycytidine-5’-triphosphate-loaded erythrocytesAIDS Res Hum Retrovir199410117911867826702
   PubMed Web of Science ®Google Scholar
• PotulaRRamirezSKnipeBPeroxisome proliferator-activated receptor-γ activation suppresses HIV-1 replication in an animal model of encephalitisAids2008221539154918670212
   PubMed Web of Science ®Google Scholar
• VinogradovSVPolymeric nanogel formulations of nucleoside analogsExpert Opin Drug Deliv20074151717184158
   PubMed Web of Science ®Google Scholar
• KuboTSugitaTShimoseSNittaYIkutaYMurakamiTTargeted delivery of anticancer drugs with intravenously administered magnetic liposomes in osteosarcoma-bearing hamstersInt J Oncol200017230931510891540
   PubMed Web of Science ®Google Scholar